LONG DANIEL D. (SVP, Drug Discovery) sold 3.3% of their position (3.33K shares) of SEPTERNA, INC. on the open market
Open‑market sale worth $114.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/2/2026ACC: 0001193125-26-295106
Officer· SVP, Drug Discovery
Since Feb 2026
-3.33K
Net shares
Net seller
$114.5K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
3.33K acquired · 6.67K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3.33K
Price / share
$2.76
Trade value
$9.20K
% of position
3.5%
7/1/2026
96.41K→99.75K
Common Stock
Direct
Shares
−2.10K
Price / share
$34.10
Trade value
$71.60K
% of position
2.1%
7/1/2026
99.75K→97.64K
Common Stock
Direct
Shares
−1.23K
Price / share
$34.81
Trade value
$42.93K
% of position
1.3%
7/1/2026
97.64K→96.41K
Total
Net shares
+0.00
Net value
-$105.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | M · Option Exercise | +3.33K | $2.76 | $9.20K | 3.5% | 96.41K | 99.75K |
| Common Stock Direct | 7/1/2026 | S · Sale | −2.10K | $34.10 | $71.60K | 2.1% | 99.75K | 97.64K |
| Common Stock Direct | 7/1/2026 | S · Sale | −1.23K | $34.81 | $42.93K | 1.3% | 97.64K | 96.41K |
| Total | +0.00 | -$105.33K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.33K shares
Shares
−3.33K
Strike price
2.76
Held after
7.04K
Exercisable
—
7/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3.33K shares | 7/1/2026 | M · Option Exercise | −3.33K | 2.76 | — | 7.04K |